Categories: Alzheimer's

7/10/2018

WSJ offers caution early and often in coverage of latest experimental Alzheimer’s drug

2/19/2018

ABC downplays gloomy context in reporting ‘remarkable’ BACE1 finding for Alzheimer’s

9/2/2016

Unlike many other news sites, NPR resists overstating results of Alzheimer’s study

7/26/2016

More backstory needed on study of ‘brain training’ benefits for dementia

1 9/28/2015

With just 226 words, NYT can’t deliver needed context on Alzheimer’s agitation study

9/16/2015

Resveratrol “may slow Alzheimer’s”? Not really

9/16/2015

Over-the-top headline aside, CNN frames resveratrol/Alzheimer’s study in cautious, accurate language

1 8/15/2015

FDA approves first computer-based dementia assessment aid; thorough Post report falls just short on key aspects of coverage

1 8/12/2015

Important Alzheimer’s topic needed a second source for context

1 7/24/2015

WSJ business story on Alzheimer’s drugs missed key aspects of health angle

Story Reviews

Systematic, Criteria-Driven

@HealthNewsRevu

Retweet on Twitter HealthNewsReview.org Retweeted

National Breast Cancer Coalition @NBCCStopBC·

A lot of interesting workshops are happening now at the #NBCCSummit! @garyschwitzer, the publisher of @HealthNewsRevu, is discussing new cancer research news. #BeBold

Reply on Twitter 1520768892888567810 Retweet on Twitter 15207688928885678101 Like on Twitter 15207688928885678103 Twitter 1520768892888567810

HealthNewsReview.org @HealthNewsRevu·

Take all the issues enmeshed in any cancer screening story and amplify it with the liquid biopsy issue. @AP's ⁦@CarlaKJohnson⁩. did a solid job here. https://apnews.com/article/science-business-health-hodgkin-lymphoma-oregon-ca899bb9c4c7f1859d4e9ce16a1cf78d

Reply on Twitter 1516522980385472513 Retweet on Twitter 1516522980385472513 Like on Twitter 15165229803854725134 Twitter 1516522980385472513